Cullinan Oncology, Inc.·4

Feb 15, 4:47 PM ET

Zawel Leigh 4

4 · Cullinan Oncology, Inc. · Filed Feb 15, 2022

Insider Transaction Report

Form 4
Period: 2022-02-11
Zawel Leigh
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-11+65,00065,000 total
    Exercise: $13.60Exp: 2032-02-10Common Stock (65,000 underlying)
  • Award

    Common Stock

    2022-02-11+32,50069,785 total
Footnotes (2)
  • [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
  • [F2]The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION